These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36073574)

  • 1. TIMP1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK/Akt signaling pathway.
    Ma B; Ueda H; Okamoto K; Bando M; Fujimoto S; Okada Y; Kawaguchi T; Wada H; Miyamoto H; Shimada M; Sato Y; Takayama T
    Cancer Sci; 2022 Dec; 113(12):4244-4257. PubMed ID: 36073574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
    Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
    J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled TIMP1 as a regulator of ferroptosis in colorectal cancer.
    Li M; Ni QY; Yu SY
    Genes Genomics; 2024 Jan; 46(1):121-133. PubMed ID: 38032469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes.
    Lee MS; Menter DG; Kopetz S
    J Natl Compr Canc Netw; 2017 Mar; 15(3):411-419. PubMed ID: 28275039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.
    Johnson SM; Gulhati P; Rampy BA; Han Y; Rychahou PG; Doan HQ; Weiss HL; Evers BM
    J Am Coll Surg; 2010 May; 210(5):767-76, 776-8. PubMed ID: 20421047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention for Colorectal Cancers: Are Chemopreventive Effects Different Between Left and Right Sided Colorectal Cancers?
    Arai J; Suzuki N; Niikura R; Ooki D; Kawahara T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Ikeya T; Arai M; Ishibashi R; Aoki T; Tsuji Y; Yamamichi N; Hayakawa Y; Fujishiro M
    Dig Dis Sci; 2022 Nov; 67(11):5227-5238. PubMed ID: 35230578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids.
    Gonzalez-Exposito R; Semiannikova M; Griffiths B; Khan K; Barber LJ; Woolston A; Spain G; von Loga K; Challoner B; Patel R; Ranes M; Swain A; Thomas J; Bryant A; Saffery C; Fotiadis N; Guettler S; Mansfield D; Melcher A; Powles T; Rao S; Watkins D; Chau I; Matthews N; Wallberg F; Starling N; Cunningham D; Gerlinger M
    J Immunother Cancer; 2019 Apr; 7(1):101. PubMed ID: 30982469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cohort study of TIMP1 as prognostic biomarker in gastric and colon cancer.
    Macedo FC; Cunha N; Pereira TC; Soares RF; Monteiro AR; Bonito N; Valido F; Sousa G
    Chin Clin Oncol; 2022 Dec; 11(6):43. PubMed ID: 36509552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism rs2682818 participates in the progression of colorectal carcinoma via miR-618-TIMP1 regulatory axis.
    Shao W; Xia H; Lan Q; Gu J; Huang H; Zheng F; Zheng Y
    Sci Rep; 2021 Nov; 11(1):23186. PubMed ID: 34848810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones.
    Tanaka J; Watanabe T; Kanazawa T; Tada T; Kazama Y; Tanaka T; Nagawa H
    J Surg Oncol; 2007 Dec; 96(7):611-8. PubMed ID: 17786961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelial‑mesenchymal transition mediated by the FAK/AKT/MMPs axis.
    Liu SQ; Xu CY; Wu WH; Fu ZH; He SW; Qin MB; Huang JA
    Int J Oncol; 2019 Jan; 54(1):41-52. PubMed ID: 30365116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway.
    Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y
    Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
    Eneh S; Heikkinen S; Hartikainen JM; Kuopio T; Mecklin JP; Kosma VM; Mannermaa A
    Anticancer Res; 2020 Jul; 40(7):3713-3722. PubMed ID: 32620610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
    Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
    Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TFF1 antagonizes TIMP-1 mediated proliferative functions in gastric cancer.
    Omar OM; Soutto M; Bhat NS; Bhat AA; Lu H; Chen Z; El-Rifai W
    Mol Carcinog; 2018 Nov; 57(11):1577-1587. PubMed ID: 30035371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinase 1 suppresses growth and differentiation of osteoblasts and differentiation of osteoclasts by targeting the AKT pathway.
    Xi Y; Huang H; Zhao Z; Ma J; Chen Y
    Exp Cell Res; 2020 Apr; 389(2):111930. PubMed ID: 32113948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing homoharringtonine for thyroid cancer treatment through TIMP1/FAK/PI3K/AKT signaling pathway.
    Xi C; Zhang G; Sun N; Liu M; Ju N; Shen C; Song H; Luo Q; Qiu Z
    iScience; 2024 Jun; 27(6):109829. PubMed ID: 38770133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.